Clinical Trial Update: Cetuximab/Paclitaxel/Cisplatin Concurrent Chemoradiotherapy Followed by Esophagectomy for Loco-regional Esophageal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating concurrent cetuximab, paclitaxel, and cisplatin chemoradiotherapy followed by esophagectomy for loco-regional esophageal cancer; curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Cetuximab (cetuximab)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Esophageal Cancer | Phase 2 | Status: UNKNOWN